A large-scale screen of tuberculosis proteins has revealed several possible antigens that could be developed as a new vaccine for TB, the world's deadliest infectious disease. Subscribe to our ...

Spain-based Biofabri, the human vaccines subsidiary of the biopharmaceutical group Zendal, has added Rolando Pajón Feyt, an international expert in immunotherapy and vaccine development, to its ...

A few weeks ago, we wrote about a positive test for latent tuberculosis and treating that infection with antibiotics. On the heels of that column, we received some follow-up questions from readers.

A team of scientists led by Oxford University have made a discovery that could improve our chances of developing an effective vaccine against Tuberculosis. The researchers have identified new ...

A large-scale screen of tuberculosis proteins has revealed several possible antigens that could be developed as a new vaccine for TB, the world's deadliest infectious disease. In the new study, a team ...

A study led by UT Southwestern Medical Center researchers has found that certain antibodies inhibit Mycobacterium ...

CAMBRIDGE, MA -- A large-scale screen of tuberculosis proteins has revealed several possible antigens that could be developed as a new vaccine for TB, the world’s deadliest infectious disease. In the ...

In the wake of a recent outbreak of tuberculosis (TB) and latent TB cases at a local San Francisco high school, IGHS's Priya ...

While all eyes have been focused on the race to develop a COVID-19 vaccine, other researchers have been furiously working on another way to defeat the coronavirus. It's a vaccine with a very long ...

More than 10,300 cases of tuberculosis were reported last year in the U.S., which is an 8% increase compared to 2023. What to ...